Uncategorized Archives - Page 30 of 251

ThursdayDec 15, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing the Seizure Treatment Market with Successful EPIL-A21-1 Animal Study

Epilepsy affects one in every 26 people globally, with as many as one million ED visits, 280 hospital admissions, average hospital stays of 3.6 days, and an aggregate hospital cost of approximately $2.5 billion annually With its severity, prevalence, and overall cost implications, Lexaria is looking to offer an alternative option with its patented DehydraTECH(TM)-CBD Its recent animal seizure study, EPIL-A21-1, showed DehydraTECH-CBD to be equally or even more effective at lower doses than Epidiolex, one of the world’s leading anti-seizure medications and the world’s only commercially approved CBD-powered anti-seizure drug Lexaria looks to build on the findings so far…

TuesdayDec 13, 2022 10:30 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) 2022 Calendar Year in Review

Lexaria Bioscience is a global innovator in drug delivery platforms whose patented DehydraTECH(TM) technology has demonstrated the ability to improve the bioavailability and increase the speed of onset of many drugs In calendar 2022, the company achieved a number of milestones in various areas, including research programs, receipt of patents, and licensing agreements Lexaria started and completed its fourth and most comprehensive hypertension study yet, investigating the capabilities of DehydraTECH-CBD, with the study showing that its formulation resulted in a sustained reduction in blood pressure over the study period (five weeks) The company has also started investigating DehydraTECH-CBD as a…

MondayDec 12, 2022 12:00 pm

REZYFi, Inc. to Benefit as Marijuana Sales Projected to Hit $53 Billion by 2026

Marijuana sales are projected to hit $33 billion in 2022, up from $3 billion in 2015, and are on track to hit $53 billion by 2026 REZYFi, a growth mortgage origination and specialized financing company, with target markets including the legalized cannabis industry, is set to be one of the key beneficiaries in this anticipated growth With the ongoing conversation around marijuana, along with the bipartisan support for its legalization, the company is optimistic that the demand for its products and services will see a spike as time progresses REZYFi still believes that financing options for cannabis-related firms will continue…

ThursdayDec 08, 2022 9:45 am

Improving Loan Origination Landscape is Positive News for Mortgage Loan Clients, Mortgage Loan Facilitator REZYFi, Inc.

Miami-based REZYFi is a mortgage lender working with traditional loans but focusing particular attention on unbanked market sectors such as the cannabis industry and those property companies that provide leases to those sectors The loan origination industry appears to be experiencing a new round of greening in reversal of the year’s difficulties In the wake of positive CPI data last month, analysts are beginning to anticipate a greening of mortgage lending rates once inflationary pressures are reduced, making it easier for companies to obtain loans for their projects The greening of inflation news last month is important news for market…

WednesdayDec 07, 2022 4:20 pm

420 with CNW — New Applications for Federal Positions Won’t Require Cannabis Use History

More than two decades after California first legalized medical cannabis, dozens of states now have their own medical and recreational cannabis markets. The cannabis industry generates billions of dollars in sales every year, proving that cannabis is one of the most popular drugs in the country even as states have loosened their policies. However, the federal government still considers cannabis a Schedule I controlled substance, meaning that even though qualifying individuals are allowed to take part in state-legal cannabis markets, their actions remain illegal at the federal level. As a result, cannabis consumers often find themselves penalized for purchasing and…

WednesdayDec 07, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Findings of Animal Anti-Seizure Study Program Suggesting that DehydraTECH(TM)-CBD Is More Effective at Lower Doses and Works More Rapidly than FDA-Approved Epidiolex

Lexaria recently announced the findings of the first two studies from its EPIL-A21-1 animal research program The program is designed to assess the effectiveness of patented DehydraTECH(TM)-CBD in reducing or eliminating seizure activity compared to Epidiolex, a CBD-based anti-seizure drug The first study evidenced that DehydraTECH-CBD is more efficacious at lower doses than Epidiolex The second study demonstrated DehydraTECH-CBD’s enhanced effectiveness; specifically, the formulation acted more rapidly than Epidiolex Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced its patented DehydraTECH(TM)-processed cannabidiol (“CBD”) formulation has demonstrated performance enhancements compared to Epidiolex(R), the first and only FDA-approved…

MondayDec 05, 2022 11:15 am

REZYFi, Inc. Eyes Developing Californian Cannabis Market Amid Approval of Ballot Measures to Expand Retail

California voters recently approved 12 local ballot measures in the 2022 midterm elections to either expand or create cannabis markets in a dozen municipalities These approvals, it is projected, will translate to over 70 new retail licenses and countless other business opportunities for plant-touching and ancillary companies that serve those retailers Having positioned itself as one of the first cannabis mortgage bankers in the United States, REZYFi’s management is confident that these approvals, coupled with the growing conversation around marijuana and its growing expansion into additional states, will significantly strengthen its brand recognition and equity The company looks to accumulate…

FridayDec 02, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Moves Forward With Exploration of Patented DehydraTECH(TM)-Processed CBD for Dementia

Approximately 55 million people worldwide have dementia, which is expected to grow to 78 million by 2030 The dementia treatment market was valued at $13.78 billion in 2021. The market is expected to grow at a CAGR of 8.32%, resulting in a value of $26.13 billion by 2029 Clinical studies have established a connection between hypertension and dementia With DehydraTECH(TM)-CBD already evidencing that it can lower blood pressure and its propensity to cross the blood-brain barrier, Lexaria is investigating the potential for a positive outcome in the DEM-A22-1 study According to the World Health Organization (“WHO”), dementia is the seventh…

WednesdayNov 30, 2022 12:00 pm

REZYFi, Inc.’s Financing Services Filling Funding Gap for Cannabis Entrepreneurs, Real Estate Owners

REZYFi is a growth mortgage origination and specialized financing company in the U.S. that primarily serves licensed and permitted cannabis companies and owners of real estate who lease to cannabis companies Entrepreneurs have for a long time faced barriers to starting cannabis businesses, including lack of access to capital, a two-tiered regulatory system, and an uneven playing field Some cities in states where medical and recreational use of marijuana is legal are working to eliminate the barriers to entry, such as Sacramento, California’s CORE program The CORE program offers benefits such as business plan development, coaching on access to capital,…

TuesdayNov 29, 2022 1:30 pm

Prime Harvest Inc. Positioned to Lead California’s Cannabis Market with Direct-to-Consumer Expansion

Prime Harvest is the parent company of Jaxx Cannabis, its D2C operations actively expanding throughout California Prime Harvest’s brand partners strongly positioned across multiple segments of the cannabis value chain Brand partners include Mary's Medicinals, STIIIZY, Lime Cannabis, and Tonik Revenue diversification is critical to sustainable growth in the cannabis industry, and it’s central to the strategy of Prime Harvest, a technology-focused, full-service cannabis corporation. With a strong portfolio of successful brand partners, Prime Harvest is strongly positioned to lead California’s sector through robust diversification across multiple segments of the cannabis value chain. “Our approach is to create strong alliances…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

Category: Uncategorized